The DUX4–HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected

The DUX4–HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected

FacioScapuloHumeral muscular Dystrophy (FSHD) is one of the most prevalent inherited muscle disorders and is linked to the inappropriate expression of the DUX4 transcription factor in skeletal muscles. The deregulated molecular network causing FSHD muscle dysfunction and pathology is not well unders...

Full description

Bibliographic Details
Main Authors:	Thuy-Hang Nguyen, Maelle Limpens, Sihame Bouhmidi, Lise Paprzycki, Alexandre Legrand, Anne-Emilie Declèves, Philipp Heher, Alexandra Belayew, Christopher R. S. Banerji, Peter S. Zammit, Alexandra Tassin
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	International Journal of Molecular Sciences
Subjects:	FSHD DUX4 HIF1α myogenesis skeletal muscle
Online Access:	https://www.mdpi.com/1422-0067/25/6/3327

Similar Items

Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures
by: Premi Haynes, et al.
Published: (2017-06-01)

Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
by: Christopher R S Banerji, et al.
Published: (2021-08-01)

Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy
by: Massimo Ganassi, et al.
Published: (2022-09-01)

Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene
by: Thuy-Hang Nguyen, et al.
Published: (2023-12-01)

DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
by: Emanuele Mocciaro, et al.
Published: (2021-11-01)

Molecular and Phenotypic Changes in FLExDUX4 Mice
by: Kelly Murphy, et al.
Published: (2023-06-01)

<i>DUX4</i> Expression in FSHD Muscles: Focus on Its mRNA Regulation
by: Eva Sidlauskaite, et al.
Published: (2020-07-01)

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
by: Matthew V Cowley, et al.
Published: (2023-05-01)

Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models
by: Andreia M. Nunes, et al.
Published: (2021-08-01)

Therapeutic Strategies Targeting DUX4 in FSHD
by: Laura Le Gall, et al.
Published: (2020-09-01)

A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
by: Virginie Mariot, et al.
Published: (2020-12-01)

Proximity ligation assay to detect DUX4 protein in FSHD1 muscle: a pilot study
by: Mary Lou Beermann, et al.
Published: (2022-05-01)

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
by: Virginie Mariot, et al.
Published: (2021-12-01)

Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele
by: Premi Haynes, et al.
Published: (2018-08-01)

Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit <i>DUX4</i> Expression
by: Ngoc Lu-Nguyen, et al.
Published: (2022-07-01)

Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy
by: Anna Karpukhina, et al.
Published: (2021-07-01)

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
by: Amy E. Campbell, et al.
Published: (2017-09-01)

Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy
by: Louise A Moyle, et al.
Published: (2016-11-01)

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy
by: Adam J. Bittel, et al.
Published: (2020-08-01)

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
by: Charis L. Himeda, et al.
Published: (2021-03-01)

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells
by: Christopher D. Sarsons, et al.
Published: (2023-09-01)

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
by: Charis L. Himeda, et al.
Published: (2022-05-01)

Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction
by: Amy E Spens, et al.
Published: (2023-04-01)

Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences
by: Thuy-Hang Nguyen, et al.
Published: (2021-07-01)

Functional domains of the FSHD-associated DUX4 protein
by: Hiroaki Mitsuhashi, et al.
Published: (2018-04-01)

The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
by: Clothilde Claus, et al.
Published: (2023-03-01)

Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD
by: Valerio Caputo, et al.
Published: (2022-08-01)

Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target
by: Philipp Heher, et al.
Published: (2022-05-01)

The complete mitochondrial genome of Sarcophaga (Liosarcophaga) dux (Diptera: Sarcophagidae)
by: Yanjie Shang, et al.
Published: (2019-01-01)

Precise Epigenetic Analysis Using Targeted Bisulfite Genomic Sequencing Distinguishes FSHD1, FSHD2, and Healthy Subjects
by: Taylor Gould, et al.
Published: (2021-08-01)

HIF-1α/MMP-9 Axis Is Required in the Early Phases of Skeletal Myoblast Differentiation under Normoxia Condition In Vitro
by: Flaminia Chellini, et al.
Published: (2023-12-01)

Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy
by: Linde F. Bouwman, et al.
Published: (2021-12-01)

Influence of <i>DUX4</i> Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
by: Elisa Duranti, et al.
Published: (2023-05-01)

DUX: One Transcription Factor Controls 2-Cell-like Fate
by: Wei Ren, et al.
Published: (2022-02-01)

The DUX-25 after Twenty-Five Years: New Analyses and Reference Data
by: Hendrik M. Koopman, et al.
Published: (2022-10-01)

Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
by: Teresa Schätzl, et al.
Published: (2021-03-01)

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with <i>DUX4</i>-Rearranged Leukaemia
by: Jacqueline A. Rehn, et al.
Published: (2020-09-01)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
by: Darko Bosnakovski, et al.
Published: (2017-10-01)

Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease
by: Ceren HANGUL, et al.
Published: (2022-09-01)

Ultramorphological study of immature stages and male genitalia of forensically significant flesh fly Sarcophaga dux thomson, 1868 (Diptera: Sarchophagidae)
by: Rohit Kumar, et al.
Published: (2021-07-01)